Wyndham (WYN) Stock Rating Kept at Stifel Nicolaus; The $130.0 Target Indicates 2.37% Potential; Keryx Biopharmaceuticals, Inc. (KERX) Had 6 Analysts Last Week

Among 15 analysts covering Keryx Biopharmaceuticals (NASDAQ:KERX), 6 have Buy rating, 2 Sell and 7 Hold. Therefore 40% are positive. Keryx Biopharmaceuticals had 36 analyst reports since July 23, 2015 according to SRatingsIntel. The firm has “Hold” rating given on Tuesday, August 2 by Stifel Nicolaus. Maxim Group maintained Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) on Thursday, February 25 with “Buy” rating. As per Wednesday, January 11, the company rating was upgraded by Citigroup. Raymond James upgraded Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) on Friday, February 26 to “Outperform” rating. The stock has “Buy” rating by TH Capital on Monday, August 10. The firm has “Buy” rating by Maxim Group given on Thursday, July 27. Morgan Stanley initiated the stock with “Underweight” rating in Thursday, August 13 report. Citigroup initiated Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) on Thursday, September 3 with “Sell” rating. JMP Securities maintained Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) on Wednesday, March 9 with “Market Outperform” rating. As per Tuesday, August 11, the company rating was initiated by FBR Capital. See Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) latest ratings:

08/11/2017 Broker: Stifel Nicolaus Rating: Hold Old Target: $7 New Target: $5 Maintain
27/07/2017 Broker: Cowen & Co Rating: Hold Maintain
27/07/2017 Broker: Maxim Group Rating: Buy New Target: $9.0000 Maintain
25/07/2017 Broker: Morgan Stanley Rating: Equal-Weight Old Target: $4 New Target: $7 Maintain

Among 12 analysts covering Wyndham Worldwide Corporation (NYSE:WYN), 7 have Buy rating, 1 Sell and 4 Hold. Therefore 58% are positive. Wyndham Worldwide Corporation has $202 highest and $63 lowest target. $108.56’s average target is -14.51% below currents $126.99 stock price. Wyndham Worldwide Corporation had 23 analyst reports since July 30, 2015 according to SRatingsIntel. The stock has “Buy” rating by Stifel Nicolaus on Friday, December 11. The firm earned “Buy” rating on Monday, October 23 by Stifel Nicolaus. Stifel Nicolaus maintained Wyndham Worldwide Corporation (NYSE:WYN) on Wednesday, June 21 with “Buy” rating. The firm earned “Hold” rating on Tuesday, July 18 by Deutsche Bank. The stock of Wyndham Worldwide Corporation (NYSE:WYN) has “Buy” rating given on Thursday, January 14 by M Partners. The stock of Wyndham Worldwide Corporation (NYSE:WYN) earned “Buy” rating by Goldman Sachs on Friday, January 19. As per Friday, April 28, the company rating was downgraded by Wolfe Research. The firm has “Neutral” rating by Credit Suisse given on Friday, February 5. The stock of Wyndham Worldwide Corporation (NYSE:WYN) earned “Buy” rating by Stifel Nicolaus on Thursday, January 18. As per Tuesday, October 17, the company rating was maintained by SunTrust.

Investors sentiment decreased to 1.5 in 2017 Q3. Its down 0.47, from 1.97 in 2017Q2. It dropped, as 12 investors sold Keryx Biopharmaceuticals, Inc. shares while 26 reduced holdings. 14 funds opened positions while 43 raised stakes. 75.60 million shares or 1.12% less from 76.46 million shares in 2017Q2 were reported. Hanson Mcclain Inc invested 0% of its portfolio in Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX). Principal Fincl owns 0% invested in Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) for 12,758 shares. Quantitative Invest Mngmt Ltd Llc reported 0.01% stake. Tower Research Lc (Trc) reported 9,868 shares. Fmr Ltd Llc has 2.24M shares for 0% of their portfolio. Eam Ltd Limited Liability Company holds 214,898 shares. Voya Inv Mgmt Ltd Com stated it has 38,137 shares or 0% of all its holdings. State Board Of Administration Of Florida Retirement owns 0% invested in Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) for 64,782 shares. The California-based Lpl Llc has invested 0% in Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX). Credit Suisse Ag invested in 0% or 120,870 shares. Nationwide Fund Advsrs reported 50,732 shares. Deltec Asset Mngmt Limited Liability Corporation has 20,000 shares. Bankshares Of New York Mellon accumulated 0% or 973,229 shares. Royal Bankshares Of Canada owns 0% invested in Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) for 8,725 shares. Barclays Public Limited Company has invested 0% in Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX).

Keryx Biopharmaceuticals, Inc., a commercial stage biopharmaceutical company, focuses on providing medicines for patients with renal disease in the United States. The company has market cap of $579.42 million. It markets its lead product Auryxia , an orally available, absorbable, iron medicine for the control of serum phosphorus levels in patients with chronic kidney disease on dialysis. It currently has negative earnings. The firm has licensing and collaboration agreements with Japan Tobacco Inc. and Torii Pharmaceutical Co., Ltd. for the development and commercialization of Auryxia in Japan.

Since October 5, 2017, it had 0 buys, and 9 sales for $84,165 activity. Another trade for 4,055 shares valued at $24,452 was made by Madison Greg on Monday, October 30. $8,472 worth of Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) was sold by Adams Brian on Monday, October 30. Another trade for 1,405 shares valued at $8,472 was sold by Neylan John F.. Holmes Scott A also sold $15,569 worth of Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) on Monday, October 30.

It closed at $4.86 lastly. It is down 13.56% since January 21, 2017 and is uptrending. It has underperformed by 3.14% the S&P500.

Since August 11, 2017, it had 0 insider buys, and 2 selling transactions for $1.80 million activity. McLester Scott G sold $1.77M worth of stock or 15,381 shares. $31,524 worth of stock was sold by HERRERA GEORGE on Friday, August 11.

Analysts await Wyndham Worldwide Corporation (NYSE:WYN) to report earnings on February, 21. They expect $1.35 earnings per share, 0.00% or $0.00 from last year’s $1.35 per share. WYN’s profit will be $136.79M for 23.52 P/E if the $1.35 EPS becomes a reality. After $2.03 actual earnings per share reported by Wyndham Worldwide Corporation for the previous quarter, Wall Street now forecasts -33.50% negative EPS growth.

Wyndham Worldwide Corporation provides hospitality services and products to individual and business clients worldwide. The company has market cap of $12.87 billion. It operates through three divisions: Hotel Group, Destination Network, and Vacation Ownership. It has a 22.76 P/E ratio. The Hotel Group segment primarily franchises hotels in the upscale, upper midscale, midscale, economy, and extended stay divisions, as well as provides property management services for full-service and select limited-service hotels.

The stock increased 3.47% or $4.26 during the last trading session, reaching $126.99. About 2.22M shares traded or 122.95% up from the average. Wyndham Worldwide Corporation (NYSE:WYN) has risen 43.20% since January 21, 2017 and is uptrending. It has outperformed by 26.50% the S&P500.

Investors sentiment decreased to 0.79 in 2017 Q3. Its down 0.03, from 0.82 in 2017Q2. It turned negative, as 33 investors sold Wyndham Worldwide Corporation shares while 196 reduced holdings. 52 funds opened positions while 128 raised stakes. 92.86 million shares or 3.09% less from 95.82 million shares in 2017Q2 were reported. Greenleaf Trust holds 0% or 100 shares. Us Retail Bank De holds 0.03% of its portfolio in Wyndham Worldwide Corporation (NYSE:WYN) for 97,410 shares. Gabelli Funds Limited Liability Com holds 0.01% in Wyndham Worldwide Corporation (NYSE:WYN) or 20,000 shares. Goldman Sachs Grp reported 0.03% of its portfolio in Wyndham Worldwide Corporation (NYSE:WYN). Quantitative Invest Management Lc has 0.16% invested in Wyndham Worldwide Corporation (NYSE:WYN). 6,241 were accumulated by Qs Limited Liability Com. Peoples Fincl Serv holds 0.01% of its portfolio in Wyndham Worldwide Corporation (NYSE:WYN) for 100 shares. Nationwide Fund holds 0.12% of its portfolio in Wyndham Worldwide Corporation (NYSE:WYN) for 283,353 shares. Missouri-based Duncker Streett And has invested 0.11% in Wyndham Worldwide Corporation (NYSE:WYN). Spark Inv Mngmt Ltd Limited Liability Company invested in 139,200 shares or 0.79% of the stock. Pensionfund Dsm Netherlands accumulated 29,000 shares. Hsbc Hldg Public Ltd holds 0.03% or 164,390 shares in its portfolio. Gateway Investment Advisers Llc accumulated 6,206 shares. Moreover, Sumitomo Mitsui Trust has 0.05% invested in Wyndham Worldwide Corporation (NYSE:WYN) for 332,302 shares. Ftb Advsr Incorporated has 0% invested in Wyndham Worldwide Corporation (NYSE:WYN) for 453 shares.